Personalis Inc - ESG Rating & Company Profile powered by AI
This report of Personalis Inc employs information from across the internet and also from available filings by Personalis Inc. This Disclosure rating includes 17 United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Reduced Inequalities' and 'Life below Water'. If you are employed by Personalis Inc and you would like to use your ESG aseessment, please get in touch.
Personalis Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 6.0, social score of 3.2 and governance score of 4.8.
4.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 816 | Pliant Therapeutics Inc | 4.8 | High |
| 816 | Voyager Therapeutics Inc | 4.8 | High |
| 837 | Personalis Inc | 4.7 | High |
| 837 | Bio Rad Laboratories Inc | 4.7 | High |
| 837 | Katakura Industries Co Ltd | 4.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Personalis Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Personalis Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Personalis Inc report the average age of the workforce?
Sign up for free to unlockDoes Personalis Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Personalis Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Personalis Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Personalis Inc offer flexible work?
Sign up for free to unlockDoes Personalis Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Personalis Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Personalis Inc conduct supply chain audits?
Sign up for free to unlockDoes Personalis Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Personalis Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Personalis Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Personalis Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Personalis Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Personalis Inc disclose water use targets?
Sign up for free to unlockDoes Personalis Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Personalis Inc have a product recall in the last two years?
Sign up for free to unlockDoes Personalis Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Personalis Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Personalis Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Personalis Inc disclose parental leave metrics?
Sign up for free to unlockDoes Personalis Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Personalis Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Personalis Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Personalis Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Personalis Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Personalis Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Personalis Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Personalis Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Personalis Inc disclose its waste policy?
Sign up for free to unlockDoes Personalis Inc report according to TCFD requirements?
Sign up for free to unlockDoes Personalis Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Personalis Inc disclose energy use targets?
Sign up for free to unlockDoes Personalis Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Personalis Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Personalis Inc
These potential risks are based on the size, segment and geographies of the company.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.